Mutations that collaborate with IL-7Ra signaling pathways to drive ALL.

@article{Rodrigues2021MutationsTC,
  title={Mutations that collaborate with IL-7Ra signaling pathways to drive ALL.},
  author={Gisele O.L. Rodrigues and Sarah D. Cramer and Hila Winer and Julie A. Hixon and Wenqing Li and Jos{\'e} Andr{\'e}s Yunes and Scott K. Durum},
  journal={Advances in biological regulation},
  year={2021},
  volume={80},
  pages={
          100788
        }
}
1 Citations
Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
TLDR
An 11-year-old boy who presented with relapsed symptomatic B-cell ALL in the myocardium following allogeneic hematopoietic stem cell transplantation is presented, an unusual presentation of relapsed ALL and this case demonstrates the associated challenges in its diagnosis and treatment.

References

SHOWING 1-10 OF 92 REFERENCES
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
TLDR
The findings indicate that IL7R mutational activation is involved in human T-cell leukemogenesis, paving the way for therapeutic targeting of IL-7R–mediated signaling in T-ALL.
Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia
TLDR
It is hypothesized that additional genetic lesions must collaborate with mutated IL7Rα or its signaling pathway members to cause leukemia, and Pediatric patient data suggested at least three potential collaborative candidates.
IL-7R is essential for leukemia-initiating cell activity and pathogenesis of T-cell acute lymphoblastic leukemia.
TLDR
It is shown that Il7r-deficient, but not wild type, mouse hematopoietic progenitors transduced with constitutively active Notch1 failed to generate leukemia upon transplantation into immunodeficient mice, thus providing formal evidence that IL-7R function is essential for Notch 1-induced T-cell leukemogenesis.
Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.
TLDR
Lmo2 cooperates with Arf loss to enhance self-renewal in primitive thymocytes to facilitate the stochastic induction of clonal CD4(+)/CD8(+) malignancies in T-ALL patients.
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
TLDR
It is revealed that some JAK1 mutation-positive T-ALLs harbor deletions of the tyrosine phosphatase PTPN2, a known negative regulator of the JAK/STAT pathway, and evidence that down-regulation of Ptpn2 sensitizes lymphoid cells toJAK1-mediated transformation and reduces their sensitivity to JAK inhibition is provided.
The clonal evolution of leukemic stem cells in T-cell acute lymphoblastic leukemia
TLDR
Relapse is associated with clonal evolution from a population of pre-LSCs that acquire the whole set of malignant mutations leading to a full-blown T-ALL, and understanding the genetic events that underpin the pre- LSC will be crucial for reducing the risk of relapse.
THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA
TLDR
Using integrated genomic analysis of 264 T-ALL cases, 106 putative driver genes are identified and new mechanisms of coding and noncoding alteration are described, which suggests that different signaling pathways have distinct roles according to maturational stage.
The genetics and molecular biology of T-ALL.
TLDR
It is revealed that T-cell progenitors accumulate additional mutations affecting JAK/STAT signaling, protein translation, and epigenetic control, providing novel attractive targets for therapy.
Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia
TLDR
It is demonstrated that activation of NOTCH1 specifically induces loss of the repressive mark lysine-27 tri-methylation of histone 3 (H3K27me3)4 by antagonizing the activity of the Polycomb Repressive Complex 2 (PRC2) complex.
...
1
2
3
4
5
...